EBS Technologies, a Kleinmachnow, Germany-based developer of therapeutic applications for the treatment of neurological disorders caused by stroke or brain injury, raised €3.0m (approximately $3.9m) in Series B funding.
Backers included Earlybird Venture Capital, High-Tech Gründerfonds and Brandenburg Capital.
Led by Ulf Pommerening and Udo Warschewske, Managing Directors, EBS Technologies recently received CE marking for its NEXT WAVE™, a brain stimulation device for treatment of neurological disorders caused by stroke and brain injury.
The company intends to use the funds to start European commercialization of its NEXT WAVE™ .
FinSMEs
11/06/2013